The Valley Desk

NCT05611931 · Interventional trial

Selinexor in Maintenance Therapy After Systemic Therapy for Participants With p53 Wild-Type, Advanced or Recurrent Endometrial Carcinoma

Overall registry status Active not recruiting

Phase 3

Conditions Endometrial Cancer

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov